Bristol Net Income from 2010 to 2026

BMY Stock  USD 60.74  0.88  1.47%   
Bristol Myers Net Income yearly trend continues to be fairly stable with very little volatility. Net Income is likely to outpace its year average in 2026. During the period from 2010 to 2026, Bristol Myers Net Income regression line of annual values had r-squared of  0.01 and arithmetic mean of  2,620,802,941. View All Fundamentals
 
Net Income  
First Reported
1987-03-31
Previous Quarter
2.2 B
Current Value
1.1 B
Quarterly Volatility
1.6 B
 
Black Monday
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Bristol Myers financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bristol Myers' main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.1 B, Interest Expense of 1.6 B or Selling General Administrative of 3.6 B, as well as many indicators such as Price To Sales Ratio of 2.92, Dividend Yield of 0.0278 or PTB Ratio of 7.0. Bristol financial statements analysis is a perfect complement when working with Bristol Myers Valuation or Volatility modules.
  
Build AI portfolio with Bristol Stock
Check out the analysis of Bristol Myers Correlation against competitors.
The evolution of Net Income for Bristol Myers Squibb provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Bristol Myers compares to historical norms and industry peers.

Latest Bristol Myers' Net Income Growth Pattern

Below is the plot of the Net Income of Bristol Myers Squibb over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Bristol Myers Squibb financial statement analysis. It represents the amount of money remaining after all of Bristol Myers Squibb operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Bristol Myers' Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bristol Myers' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 7.05 B10 Years Trend
Pretty Stable
   Net Income   
       Timeline  

Bristol Net Income Regression Statistics

Arithmetic Mean2,620,802,941
Geometric Mean3,796,617,783
Coefficient Of Variation188.58
Mean Deviation3,381,461,592
Median3,439,000,000
Standard Deviation4,942,365,179
Sample Variance24426973.6T
Range17B
R-Value0.11
Mean Square Error25723405.1T
R-Squared0.01
Significance0.67
Slope110,485,784
Total Sum of Squares390831577T

Bristol Net Income History

20267.4 B
20257.1 B
2024-8.9 B
2023B
20226.3 B
2021B
2020-9 B

Other Fundumenentals of Bristol Myers Squibb

Bristol Myers Net Income component correlations

About Bristol Myers Financial Statements

Bristol Myers investors use historical fundamental indicators, such as Bristol Myers' Net Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Bristol Myers. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Income7.1 B7.4 B
Net Income Applicable To Common Shares7.1 B7.4 B
Net Income From Continuing Ops7.1 B7.4 B
Net Income Per Share 3.46  3.63 
Net Income Per E B T 0.76  0.66 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Bristol Stock Analysis

When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.